Search

Your search keyword '"Ahmed, Mohamed E."' showing total 387 results
Start Over Author "Ahmed, Mohamed E."
387 results on '"Ahmed, Mohamed E."'

8. PD17-12 IS THERE A ROLE FOR C-11 PET-CT IN MEN WITH BIOCHEMICAL PROGRESSION OF PROSTATE CANCER AND NEGATIVE PSMA PET-CT?

Author

Basourakos, Spyridon P., primary, Ghaffar, Umar, additional, Reitano, Giuseppe, additional, Deol, Ekam, additional, Henning, Grant, additional, Mahmoud, Ahmed, additional, Nabavizadeh, Reza, additional, Pessoa, Rodrigo, additional, Ahmed, Mohamed E., additional, Kendi, Ayse T., additional, Sharma, Vidit, additional, Thompson, Houston, additional, Frank, Igor, additional, Karnes, Jeffrey, additional, Boorjian, Stephen, additional, Kwon, Eugene, additional, and Andrews, Jack, additional

Published
2024
Full Text
View/download PDF

9. PD34-03 INTRAOPERATIVE TRANEXAMIC ACID IN RADICAL CYSTECTOMY: IMPACT ON BLEEDING, THROMBOEMBOLISM, AND CANCER-SPECIFIC SURVIVAL

Author

Ahmed, Mohamed E., primary, Andrews, Jack R., additional, Mahmoud, Ahmed, additional, Thapa, Prabin, additional, Tyson, Mark D., additional, Khanna, Abhinav, additional, Shah, Paras H., additional, Sharma, Vidit, additional, Thompson, R. Houston, additional, Boorjian, Stephen A., additional, Frank, Igor, additional, Tollefson, Matthew K., additional, and Karnes, R. Jeffrey, additional

Published
2024
Full Text
View/download PDF

16. Prostate Cancer Lung Metastasis: Clinical Insights and Therapeutic Strategies

Author

Mahmoud, Ahmed M., primary, Moustafa, Amr, additional, Day, Carter, additional, Ahmed, Mohamed E., additional, Zeina, Wael, additional, Marzouk, Usama M., additional, Basourakos, Spyridon, additional, Haloi, Rimki, additional, Mahon, Mindie, additional, Muniz, Miguel, additional, Childs, Daniel S., additional, Orme, Jacob J., additional, Riaz, Irbaz Bin, additional, Kendi, A. Tuba, additional, Stish, Bradley J., additional, Davis, Brian J., additional, Kwon, Eugene D., additional, and Andrews, Jack R., additional

Published
2024
Full Text
View/download PDF

22. Prostate Cancer Lung Metastasis: Clinical Insights and Therapeutic Strategies.

Author

Mahmoud, Ahmed M., Moustafa, Amr, Day, Carter, Ahmed, Mohamed E., Zeina, Wael, Marzouk, Usama M., Basourakos, Spyridon, Haloi, Rimki, Mahon, Mindie, Muniz, Miguel, Childs, Daniel S., Orme, Jacob J., Riaz, Irbaz Bin, Kendi, A. Tuba, Stish, Bradley J., Davis, Brian J., Kwon, Eugene D., and Andrews, Jack R.

Subjects
TREATMENT of lung tumors, PROSTATE tumors treatment, DIAGNOSTIC imaging, ANTINEOPLASTIC agents, PROSTATE tumors, CHEMORADIOTHERAPY, METASTASIS, LUNG tumors, DISEASE progression
Abstract

Simple Summary: In our paper, we examine various facets of prostate cancer lung metastasis. We explore their clinical manifestations, such as respiratory symptoms and potential complications. Diagnostic modalities, including imaging techniques and biomarker analysis, are scrutinized for accurate identification. Treatment strategies, encompassing surgery, radiation therapy, chemotherapy, and targeted therapies, are discussed for their efficacy. Survival outcomes are assessed to gauge the effectiveness of different interventions. Through comprehensive analysis, we aim to provide insights into managing prostate cancer lung metastasis and enhancing patient care and outcomes. Prostate cancer lung metastasis represents a clinical conundrum due to its implications for advanced disease progression and the complexities it introduces in treatment planning. As the disease progresses to distant sites such as the lung, the clinical management becomes increasingly intricate, requiring tailored therapeutic strategies to address the unique characteristics of metastatic lesions. This review seeks to synthesize the current state of knowledge surrounding prostate cancer metastasis to the lung, shedding light on the diverse array of clinical presentations encountered, ranging from subtle radiological findings to overt symptomatic manifestations. By examining the diagnostic modalities utilized in identifying this metastasis, including advanced imaging techniques and histopathological analyses, this review aims to provide insights into the diagnostic landscape and the challenges associated with accurately characterizing lung metastatic lesions in prostate cancer patients. Moreover, this review delves into the nuances of therapeutic interventions employed in managing prostate cancer lung metastasis, encompassing systemic treatments such as hormonal therapies and chemotherapy, as well as metastasis-directed therapies including surgery and radiotherapy. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

24. The Effect of Diabetes Mellitus on Cardiac Remodeling and Overall Clinical Outcomes in Patients With Acute Myocardial Infarction: A Single-Center Retrospective Study in Saudi Arabia

Author

Albakistani, Ammar A, primary, Alqerafi, Ahmed A, additional, Marghalani, Yasir O, additional, Alasmari, Rami S, additional, Alswat, Anas M, additional, Banjar, Sereen A, additional, Allam, Reem F, additional, Ahmed, Mohamed E, additional, and Alzahrani, Atif, additional

Published
2023
Full Text
View/download PDF

25. Early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting predicts cancer-specific survival in metastatic castrate-resistant prostate cancer

Author

Ahmed, Mohamed E., primary, Lee, Matthew S., additional, Mahmoud, Ahmed M., additional, Joshi, Vidhu B., additional, Gopalakrishna, Ajay, additional, Bole, Raevti, additional, Haloi, Rimki, additional, Kendi, A. Tuba, additional, Bold, Michael S., additional, Bryce, Alan H., additional, Karnes, Robert Jeffrey, additional, Kwon, Eugene D., additional, Childs, Daniel S., additional, and Andrews, Jack R., additional

Published
2023
Full Text
View/download PDF

30. Epidemiology and risk factors of diabetic retinopathy in upper Egypt: a 3-year prospective study.

Author

Yousef, Hassan S., Ahmed, Mohamed E., Abu El Wafa, Esam A. G., and Salih, Mohamed A. K.

Subjects
*INSULIN therapy, *PEOPLE with diabetes, *ODDS ratio, *DIABETES, *EPIDEMIOLOGY, *DIABETIC retinopathy, *DYSLIPIDEMIA
Abstract

Objective To determine the prevalence and risk factors of diabetic retinopathy (DR) in adult diabetic patients during 3 years. Patients and methods This is a cross-sectional study that was carried out on the adult diabetic population who attended a large private referral ophthalmology center in Assiut City, Upper Egypt for 3 years. All cases were subjected to full history taking, ophthalmological examination, and dilated fundus examination for evidence of DR, and besides, the associated systemic complications were assessed. Results The study included a total of 2178 cases and the prevalence of DR was 18.2%. DR was more prevalent in females than males (67.9% vs. 32.1%). Also, DR was significantly associated with insulin use, moderate and poor control of diabetes mellitus, uncontrolled hypertension (HTN), dyslipidemia, and nephropathy (P<0.01 for all). The risk factors for DR were; older age (adjusted odds ratio (AOR) 1.69; 95% CI =0.91–1.97; P≤0.01), female sex (AOR 1.65; 95% CI =1.21–1.86; P =0.02), smoking (AOR 1.73; 95% CI =1.41–2.11; P =0.02), longer duration of DM (> 15 years) (AOR 2.87; 95% CI =2.48–3.29; P ≤0.01), insulin use (AOR 1.42; 95% CI =0.94–1.65; P=0.03), poor control of DM (AOR 3.98; 95% CI =3.69–5.41; P≤0.01), presence of HTN (AOR 2.62; 95% CI =2.37–2.89; P≤0.01) and dyslipidemia (AOR 1.65; 95% CI =1.42–2.02; P=0.03). Conclusion The prevalence of DR in adult diabetic patients was 18.2% and the significant risk factors for DR (arranged descendingly in power) were; poor control of DM, longer duration of DM (> 15 years), presence of HTN, smoking, high age, dyslipidemia, female sex, and insulin use. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

31. Prostate Cancer and Malignant Ascites: The Mayo Clinic Experience With a Rare and Aggressive Disease Progression.

Author

Mahmoud, Ahmed M., Orme, Jacob J., Childs, Daniel S., Ahmed, Mohamed E., Rajkumar, Anne, Kwon, Eugene D., and Andrews, Jack R.

Subjects
PROSTATE cancer, CANCER invasiveness, METASTASIS, ASCITES, PROSTATE-specific antigen
Abstract

This article presents a case series of 25 prostate cancer patients who developed malignant ascites, a rare and aggressive disease progression. The study found that malignant ascites due to prostate cancer is associated with advanced metastatic castration-resistant disease, particularly involving the liver, and poor clinical outcomes despite standard systemic therapy. The median overall survival for the whole cohort was 4 months, with no significant difference between patients who received chemotherapy and those who received supportive care. The article emphasizes the need for better systemic therapy and highlights the importance of providing the best supportive care to improve the quality of life for these patients. [Extracted from the article]

Published
2024
Full Text
View/download PDF

38. Treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasis

Author

Mahmoud, Ahmed M., primary, Childs, Daniel S., additional, Ahmed, Mohamed E., additional, Tuba Kendi, A., additional, Johnson, Geoffrey B., additional, Orme, Jacob J., additional, Stish, Bradley J., additional, Phillips, Ryan M., additional, Park, Sean S., additional, Davis, Brian J., additional, Andrews, Jack R., additional, and Kwon, Eugene D., additional

Published
2023
Full Text
View/download PDF

39. Low PSA radiographic disease progression on C11‐choline PET

Author

Mahmoud, Ahmed M., primary, Ahmed, Mohamed E., additional, Kendi, A. Tuba, additional, Thorpe, Matthew, additional, Johnson, Geoffrey B., additional, Riaz, Irbaz Bin, additional, Orme, Jacob J., additional, Kwon, Eugene D., additional, Andrews, Jack R., additional, and Childs, Daniel S., additional

Published
2023
Full Text
View/download PDF

48. Prostate Cancer: Advances in Genetic Testing and Clinical Implications

Author

Abdelrazek, Ahmad S., primary, Ghoniem, Khaled, additional, Ahmed, Mohamed E., additional, Joshi, Vidhu, additional, Mahmoud, Ahmed M., additional, Saeed, Nader, additional, Khater, Nazih, additional, Elsharkawy, Mohammed S., additional, Gamal, Ahmed, additional, Kwon, Eugene, additional, and Kendi, Ayse Tuba, additional

Published
2023
Full Text
View/download PDF

49. Concomitant vs Staged Therapeutic Inguinal Lymphadenectomy in Clinically Node Positive Penile Squamous Cell Carcinoma: Does It Make a Difference?

Author

Huelster, Heather L., primary, Chang, Andrew, additional, Rose, Kyle M., additional, Bandini, Marco, additional, Albersen, Maarten, additional, Roussel, Eduard, additional, Chipollini, Juan, additional, Zhu, Yao, additional, Ye, Ding-Wei, additional, Ornellas, Antonio A., additional, Catanzaro, Mario, additional, Marandino, Laura, additional, Pederzoli, Filippo, additional, Hakenberg, Oliver W., additional, Heidenreich, Axel, additional, Haidl, Friederike, additional, Watkin, Nick, additional, Ager, Michael, additional, Ahmed, Mohamed E., additional, Karnes, Jeffrey R., additional, Briganti, Alberto, additional, Kim, Youngchul, additional, Montorsi, Francesco, additional, Necchi, Andrea, additional, and Spiess, Philippe E., additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results